Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib

Published:2018-10-22 Issue:7 Volume:60 Page:836-845
ISSN:0284-1851
Container-title:Acta Radiologica
language:en
Short-container-title:Acta Radiol

Author:

Andersen Iben R¹^ORCID,Olesen Rene²,Boysen Anders K²,Jensen Lars H³,Mortensen Frank V⁴,Nielsen Dennis T¹,Rasmussen Finn¹

Affiliation:

1. Department of Radiology, Aarhus University Hospital, Aarhus, Denmark

2. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark

3. Department of Oncology, Lillebaelt Hospital, Vejle, Denmark

4. Department of Surgery, Aarhus University Hospital, Aarhus, Denmark

Funder

Bayer HealthCare

Publisher

SAGE Publications

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiological and Ultrasound Technology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0284185118806652

Reference30 articles.

1. Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

2. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

3. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial

4. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

5. Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Computed Tomography Perfusion Research Landscape: A Topic Modeling Study;Tomography;2023-11-01

2. Blood Perfusion Characteristics of Renal Cell Carcinoma in the Process of Tumor Growth: Monitored With Multiple Sonographic Modalities;Ultrasound Quarterly;2022-09-27

3. A Systematic Review on the Role of the Perfusion Computed Tomography in Abdominal Cancer;Dose-Response;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3